Second Sight
United States
- > Patients and Families
- > Healthcare Professionals
- > Product
- > About Us
- > Newsroom
- > Investors
- > Useful Links
- > The Argus II Prosthesis System
- > Frequently Asked Questions
- > Events
- > About The Eye
- > Glossary
- > Important Safety Information
- > Availability in the US
- > Argus II Retinal Prosthesis System
- > Clinical Outcomes
- > Surgery
- > Ongoing Clinical Trials
- > References
- > Events
- > Frequently Asked Questions
- > Important Safety Information
- > Status US Launch
- > The Argus II Retinal Prosthesis System
- > System Overview
- > How Is Argus II Designed To Produce Sight?
- > Key Features Of Argus II
- > Did You Know?
- Paper Published in BJO Shows That Argus® II Allows Letter and Word Identification in Blind Subjects
- Second Sight Medical Products Receives FDA Approval for Argus II System
- Second Sight Surpasses Major Milestone for Blind People with Retinitis Pigmentosa
- Second Sight announces First Commercial Implant of Retinal Prosthesis
- Second Sight receives CE Mark approval for the Argus® II Retinal Prosthesis System